Effects of empagliflozin on proinflammatory cytokines and other coronary risk factors in patients with type 2 diabetes mellitus: A single-arm real-world observation
Ram B. Singh(Government Medical College, Amritsar), Manoj Saxena(University of Delhi), Shashank Joshi(Unknown), Banshi Saboo(Diabetes Care & Hormone Clinic), Nar SinghVerma, Puneet Kumar(Central University of Punjab), Anuj Maheshwari, Adrián Isaza, Ján Fedačko(University of Pavol Jozef Šafárik), Viliam Mojto(Comenius University Bratislava), Ghizal Fatima(Era's Lucknow Medical College and Hospital)
Cited by 8
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Role of favipiravir in the treatment of COVID-19
|International Journal of Infectious Diseases|2020|463
May Measurement Month 2017: an analysis of blood pressure screening results worldwide
|The Lancet Global Health|2018|341
A Dielectric-Modulated Tunnel-FET-Based Biosensor for Label-Free Detection: Analytical Modeling Study and Sensitivity Analysis
|IEEE Transactions on Electron Devices|2012|304